Treatment Of Sciatica by Hijamah(cupping) therapy

Phase 2

• Conditions: Health Condition 1: G55- Nerve root and plexus compressionsin diseases classified elsewhere

• Registration Number: CTRI/2019/05/018946
• Lead Sponsor: Jamia Hamdard

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

Already diagnosed patients of sciatica presenting with all or some of the following signs and symptoms

Unilateral leg pain greater than low back pain radiating towards leg/ foot/toes

Positive straight-leg-raising sign

Numbness and/ or tingling sensation in the same distribution

Pain intensity score of 30 -60 mm on a 100-mm visual analog scale (VAS)

Willingness to accept wet cupping intervention

Exclusion Criteria

Pregnant and lactating women.

Patients of previous back surgery/ lumbar spine surgery.

Patients of spinal tumors, gross/fixed developmental deformity, cauda equine or vertebral fracture

Patients of bleeding disorders

Patients of anaemia (Hb <10gm%)

Patients taking any other conservative treatment for sciatica (NSAIDS, corticosteroids, physiotherapy, acupuncture etc.)

Patients with malignancy or any liver, kidney or heart disease

Patients of of inherited neuropathy or neuropathy attributable to other causes like hypothyroidism, vitamin B12 deficiency etc.

Motor weakness/Muscle wasting

Patients suffering from Psychiatric disorders

HIV/AIDS, HCV and HBsAg positive patients

History of stroke, severe hypertension and uncontrolled diabetes mellitus

Unwilling to participate in the study

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Relief in pain due to sciaticaTimepoint: 0 day, 42 day

Secondary Outcome Measures

Name	Time	Method
Improvement in Disability and Quality of lifeTimepoint: 0 day, 42 day